Association between COVID-19 Vaccination during Pregnancy and Safety among Infants
Clicks: 1
ID: 315697
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
0.0
/100
1 views
0 readers
AI Quality Assessment
Not analyzed
Readership in this journal
Ranked #30 of 40 articles by views in journal of the pediatric infectious diseases society
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
BACKGROUND: Vaccination during pregnancy prevents disease in both the pregnant woman and infant via transplacental antibody transfer which may interfere with infant immune response to early childhood vaccination. Data on safety of COVID-19 vaccination during pregnancy in relation to non-targeted infant infections are lacking. METHODS: We conducted a retrospective cohort study of pregnancies from May 17, 2020, through February 15, 2021, across eight integrated healthcare systems in the Vaccine Safety Datalink to evaluate receipt of COVID-19 vaccination during second or third trimester of pregnancy on medically attended encounters for infections among infants up to six months. Adjusted incidence rate ratios (aIRRs) with 95% confidence intervals were estimated, controlling for potential confounders using inverse probability of treatment weighting. RESULTS: Among 42 940 pregnancies, 14 762 (34.4%) were exposed to COVID-19 vaccination during second or third trimester. COVID-19 vaccination during second or third trimester of pregnancy was not associated with an increase in non-targeted infant medically attended respiratory infections (aIRR 0.86, 95% CI 0.77, 0.95), including respiratory syncytial virus (RSV) (aIRR 0.78, 95% CI 0.65, 0.93) and was not associated with infant bloodstream (aIRR 1.03, 95% CI 0.77, 1.37) or meningeal (aIRR 0.54, 95% CI 0.19, 1.56) infections up to six months of life. CONCLUSIONS: We found no increased risk for non-targeted medically attended infant respiratory infections and no association with bloodstream or meningeal infections from birth to six months of life following COVID-19 vaccination during second or third trimester of pregnancy. These findings, support COVID-19 vaccination safety during pregnancy on the risk of non-targeted infant infections.
| Reference Key |
openalex_W7163404523
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Elizabeth Quincer, Gabriela Vazquez‐Benitez, Eric S Weintraub, Kimp Walton, Li Wang, Kimberly K. Vesco, Michelle L. Henninger, Matthew F. Daley, Simon J. Hambidge, Jim Williams, James G. Donahue, Ousseny Zerbo, Darios Getahun, Lisa A Jackson, Candace C. Fuller, Heather S. Lipkind, Allison L. Naleway, Michael M. McNeil, Elyse O. Kharbanda |
| Journal | journal of the pediatric infectious diseases society |
| Year | 2026 |
| DOI |
10.1093/jpids/piag036
|
| URL | |
| Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.